https://www.businesswire.com/news/home/20231218981847/en/Uvax-Bio-Receives-Approval-to-Initiate-a-Phase-1-Clinical-Trial-of-Novel-HIV-1-Protein-Nanoparticle-Vaccine-Candidates-in-Australia
Uvax Bio Receives Approval to Initiate a Phase 1 Clinical Trial of Novel HIV-1 Protein Nanoparticle...
Uvax Bio receives approval to start a Phase 1 clinical study for its novel HIV-1 protein-based vaccine in Australia.